ASYLIA DIAGNOSTICS

asylia-diagnostics-logo

Asylia Diagnostics is a diagnostics technology platform intended to provide safer immunotherapy for cancer patients. We collect molecular and real-world evidence data from patients treated with investigational drugs in clinical trials and patients treated by the standard of care. We then use our data platform and AI-powered technology to transform these highly heterogeneous patient populations into well-defined subgroups that share common molecular and immuno-pathophysiology profiles. By doing t... his, we are able to identify highly specific biomarkers and novel drug targets. We then use discovered endotypes, biomarkers, and drug targets to develop patient stratification, enrichment, and indication expansion strategies, early hits/leads for the therapeutic pipeline, and eventually complex theranostic products together with our biopharma and IVD partners.

#SimilarOrganizations #People #Financial #Website #More

ASYLIA DIAGNOSTICS

Social Links:

Industry:
Artificial Intelligence (AI) Biotechnology Health Care Life Science Precision Medicine

Founded:
2019-08-22

Address:
Delaware City, Delaware, United States

Country:
United States

Website Url:
http://www.asyliadx.com

Total Employee:
1+

Status:
Active

Contact:
+32 492 40 40 24

Email Addresses:
[email protected]

Total Funding:
1.1 M USD

Technology used in webpage:
Euro Google Google Cloud Wix


Similar Organizations

akello-logo

Akello

Open Source Health Data Platform for Enterprise

carisma-therapeutics-logo

Carisma Therapeutics

Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.

perceiv-ai-logo

Perceiv AI

AI-driven precision medicine, forecasting disease progression

renovacor-logo

Renovacor

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapyโ€‘based treatments for cardiovascular disease.

sf17-therapeutics-logo

SF17 Therapeutics

SF17 Therapeutics is a precision medicine analytics platform.

verismo-therapeutics-logo

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.

Founder


not_available_image

Andrey Khmelevskiy

not_available_image

Anna Kostikova

Investors List

imec_image

imec

imec investment in Seed Round - Asylia Diagnostics

davidovs-vc_image

Davidovs Venture Collective

Davidovs Venture Collective investment in Seed Round - Asylia Diagnostics

bluehealth-innovation-center_image

BlueHealth Innovation Center

BlueHealth Innovation Center investment in Seed Round - Asylia Diagnostics

Official Site Inspections

http://www.asyliadx.com Semrush global rank: 13.31 M Semrush visits lastest month: 78

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.107
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "Asylia Diagnostics"

Asylia Diagnostics

Asylia Diagnostics focuses on the field of immunotherapies. We collect molecular, chemical and real-world evidence data. Our data come from patients treated with investigational drugs in โ€ฆSee details»

ABOUT - Asylia Diagnostics

Asylia has set up a multi-disciplinary scientific team uniquely positioned to deliver precision medicine tools thanks to a combination of technical, biological, and laboratory skills acquired โ€ฆSee details»

Asylia Diagnostics - Crunchbase Company Profile

Contact Email [email protected] Phone Number +32 492 40 40 24 Asylia Diagnostics is a diagnostics technology platform intended to provide โ€ฆSee details»

HOME | Asylia Diagnostics

Asylia Diagnostics is a precision medicine company focusing on the field of immunotherapies. We collect molecular and real-world evidence data from patients treated with investigational drugs โ€ฆSee details»

Asylia Diagnostics BV - LinkedIn

Asylia Diagnostics BV | 343 followers on LinkedIn. Diagnostics technology platform intended to provide safer immunotherapy for cancer patients | Asylia, a precision medicine platform, leverages ...See details»

Asylia Diagnostics BV Overview | SignalHire Company Profile

Organization Website: asyliadx.com : Asylia Diagnostics BV industries Biotech: Headquarters Location: Beerse, BE Beerse, BE : Asylia Diagnostics BV Employees Size 1-10 employees: โ€ฆSee details»

Asylia Diagnostics - Overview, News & Similar companies

View Asylia Diagnostics (www.asyliadx.com) location in Belgium , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

Asylia Diagnostics BV - Drug pipelines, Patents, Clinical trials

Last update 23 Jan 2025. Asylia Diagnostics BV. Startups |See details»

Asylia Diagnostic - CMOCRO

Asylia Diagnostics are building a technology platform that will permit a quick and efficient high-resolution profiling of tumor microenvironment, different immune cells and their subtypes, and โ€ฆSee details»

Asylia Diagnostics - VentureRadar

Website: https://www.asyliadx.com/ Asylia Diagnostics is a data-driven company specializing in the field of immunotherapies. They leverage a proprietary generative AI ...See details»

Asylia Diagnostics - PitchBook

Asylia Diagnostics General Information Description. Developer of molecular diagnostics tests designed to provide safer immunotherapy for cancer patients. The company's approach is based on a transformative concept that leverages โ€ฆSee details»

Nextsource | Company Profile | Asylia Diagnostics

Explore the company profile of Asylia Diagnostics (asyliadx.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»

Startup story Asylia Diagnostics - Imec.istart

Oct 21, 2020 Immunotherapy is becoming more and more effective in fighting cancer. Asylia Diagnostics develops tests to make the innovative therapy safer. โ€œBelgium is a frontrunner in โ€ฆSee details»

Asylia Diagnostics BV (Asylia Diagnostics BV) - ่ฏ็‰ฉ็ฎก็บฟ_ไธ“ๅˆฉ_ไธดๅบŠ โ€ฆ

The recent approval of ICB treatments targeting cytotoxic T-lymphocyte antigen 4 (CTLA-4) and programmed cell death-1 (PD-1/PD-L1) by the US Food and Drug Administration has offered โ€ฆSee details»

OUR APPROACH | Asylia Diagnostics

At the core of our technology is back-translation - a transformative concept that leverages molecular and clinical RWE data and machine learning/AI and allows us to de-risk upfront โ€ฆSee details»

asyliatx.com Reviews: Is this site a scam or legit?

Is asyliatx.com legit? This website has a pretty low score, which means caution is advised. We put to work 53 powerful factors to expose high-risk activity and see if asyliatx.com is safe. Let's โ€ฆSee details»

Asylia Diagnostics - VentureRadar

Similar Companies: Rosetta Omics Unknown Privately Held Rosetta Omics is dedicated to advancing precision medicine by leveraging multiomics, spatial data, and artificial intelligence. โ€ฆSee details»

Garantex Cryptocurrency Exchange Disrupted in International โ€ฆ

Mar 7, 2025 Garantex Splash Page. In conjunction with the operation targeting Garantex, the Department also announced the unsealing of an indictment in the Eastern District of Virginia โ€ฆSee details»

NEWS - Asylia Diagnostics

Our CEO Andrey Khmelevskiy had an interview with Sofie Van Poucke for Invest in Flanders.They discussed why what we do in Asylia Diagnostics BV is important for clinicians and cancer โ€ฆSee details»

PIPELINE - Asylia Diagnostics

Each disease area and drug program in our pipeline takes us one step closer to transforming preclinical R&D using computational biology, real-world evidence data, and fast โ€ฆSee details»

linkstock.net © 2022. All rights reserved